Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess ; volume:14 ; number:1 ; day:6 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (6.11.2024), 1-13, 12.2024
- Urheber
-
Wang, Bing H.
Robert, Remy
Marques, Francine Z.
Rajapakse, Niwanthi
Kiriazis, Helen
Mackay, Charles R.
Kaye, David M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-75789-0
- URN
-
urn:nbn:de:101:1-2501242107349.283641649440
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Bing H.
- Robert, Remy
- Marques, Francine Z.
- Rajapakse, Niwanthi
- Kiriazis, Helen
- Mackay, Charles R.
- Kaye, David M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
Glycyrrhizic acid induced acquired apparent mineralocorticoid excess syndrome with a hyperadrenergic state: a case report
The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study
Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
Glycyrrhizic acid induced acquired apparent mineralocorticoid excess syndrome with a hyperadrenergic state: a case report
The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study
Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
Glycyrrhizic acid induced acquired apparent mineralocorticoid excess syndrome with a hyperadrenergic state: a case report
The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism
Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study
Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists